3-(4-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)bicyclo[2.2.2]octan-1-yl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a]azocine

InChIKey	`YWNBNSZDPNFYMX-UHFFFAOYSA-N`
Compound Name	3-(4-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)bicyclo[2.2.2]octan-1-yl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a]azocine
Canonical SMILES	`Clc1ccc(-c2noc(C34CCC(c5nnc6n5CCCCCC6)(CC3)CC4)n2)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	7.26
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P28845	HSD11B1	Homo sapiens	Human	PF00106	7.9	IC50	ChEMBL;BindingDB
P80365	HSD11B2	Homo sapiens	Human	PF00106	6.6	IC50	ChEMBL;BindingDB